Clinical trial

Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects

NCT00427037 · Atlanta VA Medical Center, U.S. Fed · Completed

Key facts

NCT number NCT00427037
Title Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects
Official title Efficacy of Cholecalciferol (Vitamin D3) Therapy in Correcting Vitamin D Insufficiency and Secondary Hyperparathyroidism in Subjects With Chronic Kidney Disease: A Randomized, Placebo Controlled Pilot Study
Lead sponsor Atlanta VA Medical Center, U.S. Fed
Status Completed
Study type Interventional
Conditions Chronic Kidney Disease, Vitamin D Deficiency
Intervention type Drug
Interventions Cholecalciferol, Placebo
Enrollment 34
Start date Dec 1, 2005
Primary completion Jul 1, 2006
Completion Mar 1, 2013
First posted Jan 26, 2007
Last update posted Jul 22, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies